Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-01-01 @ 7:51 AM
Study NCT ID:
NCT02293356
Status:
UNKNOWN
Last Update Posted:
2015-08-19
First Post:
2014-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma
Sponsor:
Biotech Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
None
Primary Completion Date:
2017-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-12
Completion Date Type:
ESTIMATED
First Submit Date:
2014-10-31
First Submit QC Date:
None
Study First Post Date:
2014-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-18
Last Update Post Date:
2015-08-19
Last Update Post Date Type:
ESTIMATED